However, major drug companies can use a legal loophole to make deals with the exclusive generic maker. The move, known as 'parking', delays the 180-day period and prevents competition. The only ...
In some cases, labeling for the brand-name version refers physicians to other drugs made by the same company -- instructions the company may be able to refuse to let the generic maker copy.
Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a prominent player in the generic pharmaceuticals industry, has been garnering attention from analysts due to its recent strong performance and strategic ...
Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a prominent player in the generic and specialty pharmaceutical industry with a market capitalization of $2.45 billion, has been making significant strides in ...